Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer

By sjmartinez • July 14, 2024

Preston MA, Ebrahimi R, Hong A, Bobbili P, Desai R, Duh MS, Gandhi R, Hanson S, Dufour R, Morgans AK. Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer. Urol Oncol. 2024 Jul 12:S1078-1439(24)00499-X. doi: 10.1016/j.urolonc.2024.05.026. Epub ahead of print. PMID: 39003108.

Tags: Androgen deprivation therapy, Cardiology/Epi, cardiovascular risk, Continuous ADT, Endocrine or metabolic risk, Intermittent ADT, Nonmetastatic prostate cancer, Publications, Veterans Administration

Mid- to Late-Life Traditional Cardiovascular Risk Factor Exposure and Zero Coronary Artery Calcium: The ARIC (Atherosclerosis Risk in Communities) Study

Wang FM, Ballew SH, Folsom AR, Wagenknecht LE, Howard CM, Coresh J, Budoff MJ, Blaha MJ, Matsushita K. Mid- to Late-Life Traditional Cardiovascular Risk Factor[...]

South Asians and cardiometabolic health: A framework for comprehensive care for the individual, community, and population – An American society for preventive cardiology clinical practice statement

Rohatgi A, Anand SS, Gadgil M, Gujral UP, Jain SS, Javed Z, Jha M, Joshi PH, Manubolu VS, Nasir K, Natarajan P, Pagidipati N, Palaniappan[...]

Treated HIV infection is not associated with carotid vascular inflammation or plaque progression as assessed by dynamic contrast magnetic resonance imaging

Shakil S, Chen D, Isquith D, Sapp J, Pommier I, Chu B, Guo Y, Canton G, Balu N, Yuan C, Hatsukami T, Maynard C, Zhao[...]